Balanced news tone
News Sentiment
TFX sentiment intelligence
Teleflex Incorporated news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
83/100 classification confidence.
directly relevant articles
high-authority source matches
+1.3% over one week, +4.0% over four weeks, trend active, and below fair value.
Teleflex Inc. stock outperforms competitors on strong trading day
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Teleflex Inc. stock outperforms competitors on strong trading day
Teleflex Inc. (TFX) stock rose 1.22% to $131.75 on Wednesday, outperforming the S&P 500 Index and the Dow Jones Industrial Average on a strong trading day for the overall market. The company's shares closed 5.67% below their 52-week high achieved on April 22nd. This performance o
- Tone
- Positive 70/100
- Event
- Market update
- Published
- 15 Jul 2026 21:19
- Source
- MarketWatch
Teleflex (NYSE:TFX) Price Target Raised to $145.00 at Mizuho
Mizuho has increased its price target for Teleflex (NYSE:TFX) to $145.00 from $140.00, maintaining a "neutral" rating, which suggests a potential 10% upside. This adjustment follows Teleflex's better-than-expected quarterly results, with EPS of $1.39 and revenue of $548.3 million
- Tone
- Positive 61/100
- Event
- Analyst action
- Published
- 15 Jul 2026 19:19
- Source
- MarketBeat
Teleflex Is Maintained at Neutral by Mizuho
Mizuho has maintained its Neutral rating on Teleflex (NYSE: TFX) stock. This indicates that the analyst firm views the stock as neither an outperform nor underperform. The full article content was not provided, so details on the underlying analysis are unavailable.
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 15 Jul 2026 19:19
- Source
- Moomoo
Y Intercept Hong Kong Ltd Trims Stake in Teleflex Incorporated $TFX
Y Intercept Hong Kong Ltd significantly reduced its stake in Teleflex Incorporated by 74.8% in the first quarter, leaving it with 2,835 shares valued at $339,000. Despite this, Teleflex reported strong quarterly results with EPS of $1.39 and revenue of $548.3 million, exceeding a
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Jul 2026 11:19
- Source
- MarketBeat
Teleflex Inc (TFX) Shares Fall 4.6% -- What GF Score of 76 Tells Investors
- Tone
- Negative 22/100
- Event
- Market update
- Published
- 14 Jul 2026 23:25
- Source
- GuruFocus
Teleflex (NYSE:TFX) Trading Down 5.5% - Time to Sell?
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 14 Jul 2026 17:49
- Source
- MarketBeat
Teleflex Inc. stock underperforms Tuesday when compared to competitors
Teleflex Inc. (TFX) stock fell 4.57% on Tuesday, closing at $130.16, despite a generally positive day for the broader stock market. This decline ended a three-day winning streak for the company's shares. Both the S&P 500 Index and the Dow Jones Industrial Average saw slight gains
- Tone
- Negative 28/100
- Event
- Market update
- Published
- 14 Jul 2026 17:29
- Source
- MarketWatch
TFX4566956 Bond Profile — Key Metrics
This article provides a detailed profile of the Teleflex Incorporated 4.625% 15-NOV-2027 bond (TFX4566956). It outlines key metrics such as the issuer, issue date, maturity date, coupon rate, and face value. The profile also includes a brief description of Teleflex, Inc.'s busine
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 04:11
- Source
- TradingView
Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 13 Jul 2026 09:24
- Source
- DirectorsTalk Interviews
Teleflex stock reflects steady medical device demand amid global healthcare investment
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 11 Jul 2026 06:23
- Source
- Ad Hoc News
Teleflex (NYSE:TFX) Stock Crosses Above 200-Day Moving Average - Here's Why
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 07:39
- Source
- MarketBeat
ETFs Investing in Teleflex Incorporated Stocks
This article lists Exchange Traded Funds (ETFs) that hold shares of Teleflex Incorporated, a medical technology company. The table provides details for each ETF, including market value, weight of Teleflex stock, issuer, management style, focus, expense ratio, assets under managem
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 03:39
- Source
- TradingView
Intuitive, Globus, Teleflex named top picks as BMO initiates MedTech on buying opportunity
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 18:54
- Source
- Seeking Alpha
Teleflex stock holds steady on its medical device base
Teleflex Incorporated (TFX) maintains a steady presence in the medical device market with a broad portfolio including vascular access, anesthesia, respiratory care, and surgical products. The company's stock, listed on the NYSE, is primarily driven by operational trends like proc
- Tone
- Positive 63/100
- Event
- Market update
- Published
- 09 Jul 2026 18:46
- Source
- Ad-hoc-news.de
BMO Captal Initiates Coverage on Teleflex With Outperform Rating, $159 Price Target
- Tone
- Positive 58/100
- Event
- Analyst action
- Published
- 09 Jul 2026 12:39
- Source
- MT Newswires
Teleflex Inc. focuses on medical devices as investors track its Nasdaq listing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 10:56
- Source
- Ad Hoc News
Is Teleflex (TFX) Quietly Recasting Its Interventional Cardiology Ambitions Through the BIOMAG Trials?
Teleflex (TFX) is advancing its cardiovascular portfolio with new developments in its BIOMAG clinical trials for resorbable magnesium scaffolds. These trials, alongside strategic portfolio reshaping and leadership changes, suggest Teleflex is aiming for a stronger position in com
- Tone
- Positive 64/100
- Event
- Market update
- Published
- 09 Jul 2026 10:41
- Source
- Sahm
Teleflex Inc. focuses on medical devices and long-term growth
Teleflex Inc. is a global supplier of medical devices integral to critical care and surgical procedures, reflecting its strong position in healthcare technology. The company's focus on essential medical tools and recurring demand for its products makes it a long-term play for inv
- Tone
- Positive 75/100
- Event
- Macro sensitivity
- Published
- 08 Jul 2026 06:11
- Source
- AD HOC NEWS
Teleflex Publishes 2025 Global Impact Report
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 10:30
- Source
- Business Wire
Teleflex (TFX) Starts BIOMAG III As Freesolve Progress Tests Its Fair Value Story
Teleflex (TFX) has initiated enrollment for its global BIOMAG-III Study and achieved key milestones in earlier BIOMAG trials, which are assessing the Freesolve Resorbable Magnesium Scaffold. The company's stock has seen a recent rebound, with a 16.47% 90-day return and a 13.03% 1
- Tone
- Positive 61/100
- Event
- Market update
- Published
- 06 Jul 2026 21:46
- Source
- Sahm
Teleflex Inc focuses on medical devices as investors watch long term growth
Teleflex Inc. is a global medical technology company specializing in devices for critical care and surgical procedures. The company's diversified portfolio, focus on innovation, and presence in high-demand segments like vascular access position it for long-term growth, making it
- Tone
- Positive 75/100
- Event
- Market update
- Published
- 06 Jul 2026 17:42
- Source
- AD HOC NEWS
Teleflex Incorporated (TFX) Stock Analysis: Exploring an 8.88% Potential Upside Amid Strong Revenue Growth
- Tone
- Positive 95/100
- Event
- Earnings
- Published
- 06 Jul 2026 09:25
- Source
- DirectorsTalk Interviews
Teleflex Inc. focuses on specialty medical devices amid steady demand
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 05 Jul 2026 08:41
- Source
- Ad Hoc News
The Teleflex Arrow EZ-IO System. A rugged emergency access tool built for seconds
The Teleflex Arrow EZ-IO System is an intraosseous vascular access device designed for rapid delivery of medications and fluids directly into bone marrow when traditional IV access is difficult. It is widely used by first responders and medical professionals in emergency situatio
- Tone
- Positive 74/100
- Event
- Market update
- Published
- 05 Jul 2026 02:09
- Source
- AD HOC NEWS
Teleflex Q1 2026 slides: earnings beat amid margin pressure, buyback starts early
Teleflex (NYSE: TFX) exceeded Q1 2026 earnings and revenue expectations despite significant margin pressure from tariffs and integration costs. The company reported adjusted EPS of $1.39 and revenue of $548.3 million, driven by strong performance in the Surgical segment and the r
- Tone
- Positive 70/100
- Event
- Earnings
- Published
- 04 Jul 2026 20:11
- Source
- Investing.com
If You Invested $1,000 in Teleflex Inc (TFX)
This article analyzes the historical performance of investing $1,000 in Teleflex Inc (TFX) over 1, 5, and 10 years, showing varying returns and underperformance compared to the S&P 500. It also provides an overview of Teleflex Inc, a global medical technology company, detailing i
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 08:09
- Source
- Stock Titan
Teleflex Inc. updates its medtech portfolio as investors weigh long-term growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 Jul 2026 20:06
- Source
- Ad Hoc News
TFX - Teleflex Incorporated Earnings
This article provides a comprehensive snapshot of Teleflex Incorporated (TFX) financial data and key performance indicators. It covers market valuation, income statement figures, dividend information, analyst estimates, insider and institutional ownership, and various stock perfo
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 03 Jul 2026 07:40
- Source
- Finviz
Teleflex Dodges Bid to Revive Patent Case Over Laryngoscopes
Teleflex Medical Inc. successfully fended off an attempt to revive a patent infringement lawsuit concerning its video laryngoscopes. The US Court of Appeals for the Federal Circuit affirmed that the medical device did not infringe on Jonathan Berrall's patent under the doctrine o
- Tone
- Positive 66/100
- Event
- Regulatory and legal
- Published
- 02 Jul 2026 18:15
- Source
- Bloomberg Law News
Teleflex Inc. stock underperforms Thursday when compared to competitors despite daily gains
Teleflex Inc. (TFX) shares rose 3.27% to $133.99 on Thursday. This gain occurred during a mixed trading session where the S&P 500 remained mostly unchanged and the Dow Jones Industrial Average rose. Despite its daily gains, the stock underperformed compared to its competitors.
- Tone
- Positive 64/100
- Event
- Market update
- Published
- 02 Jul 2026 17:26
- Source
- MarketWatch